Technology | June 11, 2012

MIMneuro to Add Quantitative Analysis of Amyloid PET Images

June 11, 2012 — MIM Software is currently preparing MIMneuro version 5.5.0 for release in June. MIMneuro is vendor-neutral software indicated for quantitative and statistical analysis to aid in the interpretation of PET (positron emission tomography) and SPECT (single photon emission computed tomography) brain images. The new version will include two enhancements to make it well suited for quantitative analysis of amyloid PET images.

The BrainAlign deformable registration algorithm now includes the ability to deformably register to multiple templates simultaneously. With this landmark-based deformable registration approach, local differences in anatomy are resolved more accurately than with affine registration. The variability in uptake patterns with targeted tracers such as amyloid confounds single template registration approaches.  By simultaneously using multiple templates, the BrainAlign algorithm registers these images.

Additionally, MIM Software has worked with experts to define and release its third anatomical brain atlas. This probabilistic amyloid atlas is a tool specifically tuned for performing quantitative regional analysis on amyloid PET images.

MIMneuro combines these new features with existing tools – including voxel-based analysis, region-based analysis, SUVR computation, cluster analysis and surface projection analysis – into comprehensive quantitative functional neuroimaging software.

For more information: www.mimsoftware.com

Related Content

MRI and Computer Modeling Reveals How Wrist Bones Move

Using fast MRI, UC Davis researchers scanned left and right wrists of men and women and used the data to build computer models of the movement of wrist bones. The data could help understand wrist injuries such as carpal tunnel syndrome. Image courtesy of Brent Foster and Abhijit Chaudhari, UC Davis.

News | Magnetic Resonance Imaging (MRI) | February 19, 2019
In a just-published Journal of Biomechanics article, the researchers proved a longtime assumption about individuals'...
Synopsys Releases Simpleware ScanIP Medical Software for 3-D Printing
Technology | Medical 3-D Printing | February 14, 2019
Smart technology company Synopsys recently announced the release of the Synopsys Simpleware ScanIP Medical edition for...
Medivis Launches SurgicalAR Augmented Reality Platform
Technology | Advanced Visualization | February 14, 2019
Medical imaging and visualization company Medivis officially unveiled SurgicalAR, its augmented reality (AR) technology...
Survey Finds Personalized Patient Engagement Improving But Still Lacking
News | Patient Engagement | February 12, 2019
Software company Pegasystems Inc. announced new survey data revealing the positive impact of quality patient engagement...
Standards-based interoperability is the key to the use of components critically important to Vital Images’ vision of enterprise imaging

Standards-based interoperability is the key to the use of components critically important to Vital Images’ vision of enterprise imaging. Graphic courtesy of Vital Images

Feature | Artificial Intelligence | February 11, 2019 | By Greg Freiherr
Vital Images has reconciled its vision of the distant future with near term reality.
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
Sponsored Content | Videos | Information Technology | February 07, 2019
In this video Johann Fernando, Ph.D., Chief Operating Officer of...
Sponsored Content | Videos | Artificial Intelligence | February 01, 2019
Artificial intelligence can do more than assist in the interpretation of patient images.
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
EBM Technologies Earns FDA Clearance for iPad Pro-Based Radiology Viewing System
Technology | Remote Viewing Systems | January 29, 2019
EBM Technologies announced that its vendor-neutral, remote reading system [email protected] has been granted Class II U.S. Food and...